Frontier Medicines

Frontier Medicines is a clinical-stage precision medicine company that is dedicated to developing transformative therapies against previously "undruggable" disease-causing targets. They have developed a proprietary platform, the Frontier™ Platform, which utilizes chemoproteomics, covalent chemistry, and machine learning to unlock the proteome and discover new drug targets. Their approach is focused on delivering precision medicines for genetically-defined patient populations, beginning with oncology and immunology.

Frontier Medicines has a diverse pipeline of wholly-owned precision medicines against the most important drivers of cancer and high-value immunology programs. Their lead candidate, FMC-376, is a dual inhibitor of ON+OFF KRASG12C, which is a potential best-in-class therapy designed to completely block both forms of the KRAS mutation to overcome the lack of response and resistance seen with single-acting KRASG12C inhibitors. Frontier Medicines is committed to advancing science and delivering breakthrough medicines to patients.

Frontier Medicines offers employees a flexible work environment with benefits that include flexible time off and a competitive compensation package. The company also provides employees with a variety of community benefits, including an employee assistance program, mentorship program, company-sponsored meals, and group activities.

Frontier Medicines offers a comprehensive benefits package for its employees, encompassing both financial and health-related aspects. They provide competitive compensation, a 401k savings plan, flexible time off, and medical, dental, and vision insurance. Additionally, they offer benefits that foster a strong sense of community, such as an Employee Assistance Program, mentorship programs, company-sponsored meals, and group activities. These benefits aim to support employee well-being, financial security, and overall satisfaction.

Frontier Medicines is a precision medicine company committed to developing innovative therapies that target disease-causing proteins previously deemed undruggable. Their mission is to expand the universe of therapeutic possibilities by unlocking the proteome to develop breakthrough medicines for patients with a focus on oncology. They utilize a proprietary platform that combines chemoproteomics, covalent drug discovery, and machine learning to identify and pharmacologically target pockets within disordered regions and cryptic binding sites on these proteins, making them accessible to therapeutic intervention by small-molecule drugs.

Frontier Medicines fosters a collaborative and driven work environment where employees are passionate about science and patient-centricity. The company values boldness and excellence, promoting a culture of teamwork and innovation, where individuals are encouraged to contribute their unique skills and perspectives. Frontier prioritizes employee well-being, offering competitive benefits and a supportive work-life balance, all while celebrating achievements and fostering a sense of community.

Frontier Medicines is committed to fostering a diverse, equitable, and inclusive workplace. They believe that a diverse workforce, representing a broad range of backgrounds, perspectives, and experiences, is essential for driving innovation and achieving their mission of delivering breakthrough medicines. The company actively promotes a culture of respect and belonging, where all employees feel valued, supported, and empowered to contribute their best work. Frontier is dedicated to attracting, developing, and retaining talent from all walks of life, and actively seeks out and supports diverse individuals to join their team.